VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
VaxCT
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Pathogen Page
Cancer

Table of Contents

  1. General Information
    1. Disease
    2. Introduction
  2. Vaccine Related Pathogen Genes
    1. 7299
    2. AAV2gp02 (Adeno-associated virus - 2)
    3. ABALON (Homo sapiens)
    4. ABL2 (Homo sapiens)
    5. ACP3 (Homo sapiens)
    6. ACPP (Homo sapiens)
    7. ADAM17 (Homo sapiens)
    8. AFP (Homo sapiens)
    9. AFP from human-Obsolete (Homo sapiens)
    10. ag85A (Mycobacterium tuberculosis H37Rv)
    11. AIM2 (Homo sapiens)
    12. AKAP4 (Homo sapiens)
    13. AKT1 (Homo sapiens)
    14. ALDH1A1 (Homo sapiens)
    15. ALDH2 (Homo sapiens)
    16. ANTXR1 (Homo sapiens)
    17. AR (Homo sapiens)
    18. asdfaf asf
    19. ASTE1 (Homo sapiens)
    20. ATL1 (Homo sapiens)
    21. B4GALNT1 (Homo sapiens)
    22. BCAP31 (Homo sapiens)
    23. BCL2L1 (Homo sapiens)
    24. CA9 (Homo sapiens)
    25. CCL21 (Homo sapiens)
    26. Ccl21a (Mus musculus)
    27. CCNG1 (Homo sapiens)
    28. CCNI (Homo sapiens)
    29. CCR5 (Homo sapiens)
    30. CCR7 (Homo sapiens)
    31. CD19 (Homo sapiens)
    32. CD1D (Homo sapiens)
    33. CD22 (Homo sapiens)
    34. CD33 (Homo sapiens)
    35. CD38 (Homo sapiens)
    36. CD3D (Homo sapiens)
    37. CD40 (Homo sapiens)
    38. Cd40lg (Mus musculus)
    39. CD40LG (Homo sapiens)
    40. CD44 (Homo sapiens)
    41. CD55 (Homo sapiens)
    42. CD58 (Homo sapiens)
    43. CD70 (Homo sapiens)
    44. Cd80 (Mus musculus)
    45. CD80 (Homo sapiens)
    46. Cd86 (Mus musculus)
    47. CD86 (Homo sapiens)
    48. CD8A (Homo sapiens)
    49. CD90 (Homo sapiens)
    50. CDH3 (Homo sapiens)
    51. CDK1 (Homo sapiens)
    52. cdsR (Chlamydia trachomatis A/HAR-13)
    53. Cea-Mouse (Mus musculus)
    54. CEACAM1 (Homo sapiens)
    55. CEACAM3 (Homo sapiens)
    56. CEACAM5 (CEA) (Homo sapiens)
    57. CEACAM5 - obsolete (Homo sapiens)
    58. CHI3L1 (Homo sapiens)
    59. CLEC3B (Homo sapiens)
    60. CLEC4C (Homo sapiens)
    61. CRY2 (Arabidopsis thaliana)
    62. CSF1R (Homo sapiens)
    63. Csf2-Mouse (Mus musculus)
    64. CSH1 (Homo sapiens)
    65. CTAG1B (Homo sapiens)
    66. CTAG2 (Homo sapiens)
    67. CTLA4 (Homo sapiens)
    68. cupB5 (Pseudomonas aeruginosa PAO1)
    69. CYP1B1 (Homo sapiens)
    70. DCT (Homo sapiens)
    71. DCT (Homo sapiens)
    72. DDR1 (Homo sapiens)
    73. DEPDC1 (Homo sapiens)
    74. DItox
    75. E1B (Human mastadenovirus C)
    76. E2A (Mus musculus)
    77. E6 (Human papillomavirus type 16)
    78. E7 (Human papillomavirus type 16)
    79. EBNA-1 (Human gammaherpesvirus 4)
    80. EGFR (Homo sapiens)
    81. Emb (Mus musculus)
    82. Eng (Mus musculus)
    83. ENG (Homo sapiens)
    84. env (Human immunodeficiency virus 1)
    85. EPCAM (Homo sapiens)
    86. EPHA2 (Homo sapiens)
    87. ERBB2 (Homo sapiens)
    88. Erbb2 (Rattus norvegicus)
    89. EWSR1 (Homo sapiens)
    90. Fasl (Mus musculus)
    91. FASLG (Homo sapiens)
    92. FCY1 (Saccharomyces cerevisiae S288C)
    93. FGF2 (Homo sapiens)
    94. FGF5 (Homo sapiens)
    95. FIM3 (Homo sapiens)
    96. FL1 (Homo sapiens)
    97. FLT1 (Homo sapiens)
    98. Flt3 (Mus musculus)
    99. FLT3LG (Homo sapiens)
    100. FOLH1 (Homo sapiens)
    101. FOLR1 (Homo sapiens)
    102. Fosl1 (Mus musculus)
    103. FOXO1 (Homo sapiens)
    104. Fragment C from tetanus toxin (Clostridium tetani)
    105. FUS (Homo sapiens)
    106. GAA (Homo sapiens)
    107. GALC (Homo sapiens)
    108. Gla (Mus musculus)
    109. GLIPR1 (Homo sapiens)
    110. GM-CSF (Papio anubis)
    111. GM-CSF (human) (Homo sapiens)
    112. GM-CSF (Mus musculus) (Mus musculus)
    113. GM2A (Homo sapiens)
    114. GNRH1 (Homo sapiens)
    115. Gnrh1 (Mus musculus)
    116. gp100 (PMEL) (Homo sapiens)
    117. gp160
    118. gp72 (Human herpesvirus 4 type 2)
    119. GPC3 (Homo sapiens)
    120. GPR183 (Homo sapiens)
    121. GPT (Homo sapiens)
    122. GRDX (Homo sapiens)
    123. GRIN1 (Homo sapiens)
    124. GRP (Homo sapiens)
    125. GUCY2C (Homo sapiens)
    126. H2-K1 (Mus musculus)
    127. HA (Influenza A virus (A/California/07/2009(H1N1)))
    128. HBB (Homo sapiens)
    129. HBsAg (Hepatitis B virus)
    130. HER2-Dupli
    131. HLA-A (Homo sapiens)
    132. HLA-B (Homo sapiens)
    133. HLA-DRB1 (Homo sapiens)
    134. HPV6 E6 (Human papillomavirus type 6)
    135. HPV6 E6 (Human papillomavirus type 6)
    136. HRAS (Homo sapiens)
    137. HSP47 (Mus musculus)
    138. HSP90B1 (Homo sapiens)
    139. HSPA4 (Homo sapiens)
    140. HSPD1 (Homo sapiens)
    141. HuD (Homo sapiens)
    142. human TP53 (P53) (Homo sapiens)
    143. HUMGP 75 (Homo sapiens)
    144. ICAM1 (Homo sapiens)
    145. ID1 (Homo sapiens)
    146. IDH1 (Homo sapiens)
    147. IDO1 (Homo sapiens)
    148. IFNA2 (Homo sapiens)
    149. IFNB1 (Homo sapiens)
    150. IFNG (Homo sapiens)
    151. IFNG- Obsolete (Homo sapiens)
    152. IFNL3 (Homo sapiens)
    153. IGF2BP3 (Homo sapiens)
    154. IGFBP1 (Homo sapiens)
    155. IgG Fc (Homo sapiens)
    156. IGHG1 (Homo sapiens)
    157. IL12 (Sus scrofa)
    158. IL12A (Homo sapiens)
    159. IL12B (Homo sapiens)
    160. IL13RA2 (Homo sapiens)
    161. Il18 (Mus musculus)
    162. IL2 (Homo sapiens)
    163. IL2-Duplicate (Homo sapiens)
    164. IL24 (Homo sapiens)
    165. IL3RA (Homo sapiens)
    166. Immunoglobulin (Homo sapiens)
    167. ITGB8 (Homo sapiens)
    168. ITIH4 (Homo sapiens)
    169. JUP (Homo sapiens)
    170. KDR (Homo sapiens)
    171. Kdr (Mus musculus)
    172. KIF20B (Homo sapiens)
    173. KLK3 (Homo sapiens)
    174. KLK3-Dupli (Homo sapiens)
    175. KRAS (Homo sapiens)
    176. KRAS (Homo sapiens)
    177. L1 (Human papillomavirus)
    178. lacZ (Escherichia coli str. K-12 substr. MG1655)
    179. LADD-Ag
    180. LILRA2 (Homo sapiens)
    181. LMP-1 (Human gammaherpesvirus 4)
    182. LMP-2A (Human gammaherpesvirus 4)
    183. LV28_RS26095 transcriptional regulator RegF (Pandoraea pnomenusa)
    184. LY6K (Homo sapiens)
    185. MAGE-1 (Homo sapiens)
    186. MAGEA1 (MAGE1) (Homo sapiens)
    187. MAGEA1-Duplicate
    188. MAGEA10 (Homo sapiens)
    189. MAGEA2 (Homo sapiens)
    190. MAGEA3 (Homo sapiens)
    191. MAGEA6 (Homo sapiens)
    192. MAGEA9 (Homo sapiens)
    193. MAGEC1 (Homo sapiens)
    194. MAGEC2 (Homo sapiens)
    195. major capsid protein L1
    196. MBL2 (Homo sapiens)
    197. Mcam (Mus musculus)
    198. MDM2 (Homo sapiens)
    199. MFGE8 (Homo sapiens)
    200. MGMT (Homo sapiens)
    201. Mice Gene
    202. MLANA (Homo sapiens)
    203. MLANA-Dupli (Homo sapiens)
    204. mouse Trp53 (Mus musculus)
    205. MOV10 (Homo sapiens)
    206. MS4A1 (Homo sapiens)
    207. MSLN (Homo sapiens)
    208. MUC1 (Homo sapiens)
    209. Muc1 (Mus musculus)
    210. MUC16 (Homo sapiens)
    211. MUC2 (Homo sapiens)
    212. MUC5B (Homo sapiens)
    213. NF2 (Homo sapiens)
    214. NRAS (Homo sapiens)
    215. NRP1 (Homo sapiens)
    216. NSCLC
    217. NUF2 (Homo sapiens)
    218. NY-ESO-1 (Homo sapiens)
    219. ny-eso-1
    220. ORF68 (Human alphaherpesvirus 3)
    221. P10
    222. PAEP (Homo sapiens)
    223. PAGR1 (Homo sapiens)
    224. PAP (Mus musculus)
    225. Pap antigen (Homo sapiens)
    226. PAX3 (Homo sapiens)
    227. PDCD1 (Homo sapiens)
    228. Pdgfrb (Mus musculus)
    229. PMEL - OBSOLETE (Homo sapiens)
    230. PMEL - obsolete (Homo sapiens)
    231. Pmel17 (Mus musculus)
    232. pp65 (Mus musculus)
    233. PRAME (Homo sapiens)
    234. Prn (Mus musculus)
    235. PROM1 (Homo sapiens)
    236. Prostate specific antigen (Mus musculus)
    237. Prostate stem cell antigen (Mus musculus)
    238. Prostate-specific membrane antigen (Homo sapiens)
    239. Prostate-specific membrane antigen (Rattus norvegicus)
    240. PSMB9 (Homo sapiens)
    241. PTPRC (Homo sapiens)
    242. PTTG1 (Homo sapiens)
    243. RANBP2 (Homo sapiens)
    244. RHD (Homo sapiens)
    245. RNF43 (Homo sapiens)
    246. ROPN1 (Homo sapiens)
    247. Rpsa (Mus musculus)
    248. RUNX1 (Homo sapiens)
    249. S (Hepatitis B virus)
    250. S100A6 (Homo sapiens)
    251. S100A9 (Homo sapiens)
    252. SCFV (Homo sapiens)
    253. SCGB2A2 (Homo sapiens)
    254. SDC1 (Homo sapiens)
    255. SDC1-Obsolete (Homo sapiens)
    256. sialyl-Tn
    257. SILV (Homo sapiens)
    258. SLAMF7 (Homo sapiens)
    259. SLC5A5 (Homo sapiens)
    260. SOX2 (Homo sapiens)
    261. SOX6 (Homo sapiens)
    262. SPA17 (Homo sapiens)
    263. SPANXB1 (Homo sapiens)
    264. SPBC17D11.03c hypothetical protein (Schizosaccharomyces pombe)
    265. SPY-1
    266. ST8SIA1 (Homo sapiens)
    267. Steap1 (Mus musculus)
    268. STEAP1 (Homo sapiens)
    269. Survivin (Homo sapiens)
    270. Survivin (Mus musculus)
    271. TAF1B (Homo sapiens)
    272. TARP (Homo sapiens)
    273. TBXT (Homo sapiens)
    274. TERT (Homo sapiens)
    275. TET1 (Homo sapiens)
    276. tetX (Clostridium tetani E88)
    277. TF (Homo sapiens)
    278. TGFB2 (Homo sapiens)
    279. Th (Mus musculus)
    280. TLR4 (Homo sapiens)
    281. TLR7 (Homo sapiens)
    282. TLR9 (Homo sapiens)
    283. TMEM37 (Homo sapiens)
    284. TNF (Homo sapiens)
    285. tnf-alpha (Oncorhynchus mykiss)
    286. TNFRSF18 (Homo sapiens)
    287. TNFSF10 (Homo sapiens)
    288. TNFSF18 (Homo sapiens)
    289. TOMM34 (Homo sapiens)
    290. TOP2A (Homo sapiens)
    291. tox1 (Corynebacterium diphtheriae PW8)
    292. TP53 - delete (Homo sapiens)
    293. TPBG (Homo sapiens)
    294. TRP-1 (Mus musculus)
    295. TRP-2 (Homo sapiens)
    296. Trp2 (Mus musculus)
    297. TRPC1 (Homo sapiens)
    298. Tumor Associated Antigen
    299. Tyrosinase (Homo sapiens)
    300. Tyrosinase from Mouse (Mus musculus)
    301. TYRP1 (Homo sapiens)
    302. Tyrp1 (Mus musculus)
    303. Ubiquitin (Mus musculus)
    304. UL122 (Human betaherpesvirus 5)
    305. UL123 (Human betaherpesvirus 5)
    306. UL83 (Human betaherpesvirus 5)
    307. UL83 (Human betaherpesvirus 5)
    308. UL97
    309. VEGFA (Homo sapiens)
    310. VHL (Homo sapiens)
    311. WHcAg (Woodchuck hepatitis virus)
    312. WT1 (Homo sapiens)
    313. Xbp1 (Mus musculus)
    314. XBP1 (Homo sapiens)
    315. Xcl1 (Mus musculus)
    316. XCL1 (Homo sapiens)
    317. YBX1 (Homo sapiens)
  3. Vaccine Information
    1. (H115D)VHL35 Peptide Vaccine
    2. 1(SOCS1)-silenced dentritic cell (DC) vaccines
    3. 117-126:FGF-5 Peptide
    4. 12MP
    5. 12MP, 12MP/Tet, 12MP/6MHP, or 6MHP
    6. 15Tn-MUC1 60-mer Glycopeptide-KLH Conjugate Vaccine
    7. 27-35(27L):MART-1 peptide vaccine
    8. 3′-fluoro-6TF–MUC1–BSA conjugate vaccine
    9. 4'F-6TF-MUC1(20)-TTox Conjugate Vaccine
    10. 4-peptide melanoma vaccine
    11. 6F-Tn-MUC1-alpha-GalCer Nanoliposomal Vaccine
    12. 851B Gel
    13. A2/4-1BBL melanoma vaccine
    14. Abagovomab
    15. AcDEX-(imine) Nanoparticle Vaccine Conjugated to MUC1 Epitopes (TSAPDTRPAP/SAPDNRPAL) and R837
    16. Ad CMV I kappaB alpha
    17. Ad-sig-hMUC-1/ecdCD40L Vaccine
    18. Ad5 Vector Signal-hMUC1/CD40L Extracellular Domain Vaccine
    19. Ad5-yCD/mutTKSR39rep-hIL12
    20. Ad5F35-LMP1/LMP2-Transduced Autologous Dendritic Cells
    21. Adenovector Encoding MDA7
    22. Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201
    23. Adenoviral Vector Ad5-CEA(6D) Vaccine
    24. Adenovirus 5-CD40 Ligand
    25. Adenovirus 5-Fibroblast Growth Factor 2
    26. Adenovirus 5-Human Guanylyl Cyclase C-PADRE Vaccine
    27. Adenovirus B7-1
    28. Adenovirus Encoding Rat HER-2/neu
    29. Adenovirus Encoding Tyrosinase/MART-1/MAGEA6-transduced Autologous Dendritic Cell Vaccine
    30. Adenovirus HER2-Transduced Autologous Dendritic Cell Vaccine
    31. Adenovirus RSV-TK
    32. Adenovirus-mediated Human Interleukin-12
    33. Adenovirus-p53 Transduced Dendritic Cell Vaccine
    34. Adenovirus-PSA Prostate Cancer Vaccine
    35. adenovirus-transfected autologous DC vaccine plus CIK cells
    36. Adenovirus-vectored therapeutic vaccine (Ad-Ii-E1E2E6E7)
    37. AdRTVP-1-Transduced Prostate Cancer Cell-Based Vaccine
    38. AE37 Peptide/GM-CSF Vaccine
    39. AFP Gene Hepatocellular Carcinoma Vaccine
    40. Ag NY-ESO-1
    41. AGS-003-BLD Vaccine
    42. AIM2(-1)/HT001(-1)/TAF1B(-1) Frameshift Peptide Vaccine
    43. Algenpantucel-L
    44. ALK peptide vaccine
    45. Allogeneic AML Antigen-expressing Dendritic Cell Vaccine
    46. Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine
    47. Allogeneic Cellular Vaccine 1650-G
    48. Allogeneic Dendritic Cell Vaccine COMBIG-DC
    49. Allogeneic Dendritic Cell-Myeloma Idiotype Vaccine
    50. Allogeneic Glioblastoma Stem-like Cell Line Lysate-pulsed Autologous Dendritic Cell Vaccine
    51. Allogeneic GM-CSF-Based Myeloma Cell Vaccine
    52. Allogeneic GM-CSF-Secreting Breast Cancer Vaccine
    53. Allogeneic GM-CSF-secreting Lethally Irradiated Pancreatic Tumor Cell Vaccine
    54. Allogeneic GM-CSF-secreting Tumor Vaccine PANC 10.05 pcDNA-1/GM-Neo
    55. Allogeneic GM-CSF-secreting Tumor Vaccine PANC 6.03 pcDNA-1/GM-Neo
    56. Allogeneic HLA-A2/4-1BB ligand-expressing Melanoma Vaccine
    57. Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine
    58. Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307
    59. Allogeneic Melanoma Vaccine AGI-101H
    60. Allogeneic Mesothelioma Tumor Lysate-pulsed Autologous Dendritic Cell Vaccine
    61. Allogeneic Multipotent Adult Progenitor Cells
    62. Allogeneic Renal Cell Carcinoma Vaccine MGN1601
    63. Allogeneic Tumor Cell Vaccine
    64. Allogeneic/Syngeneic DC-MC38/MUC1 Fusion Cell Vaccine
    65. Allogenic Glioma Cancer Vaccine
    66. Alpha Fetoprotein Adenoviral Vector Vaccine
    67. Alpha Fetoprotein Plasmid DNA Vaccine
    68. Alpha-1,3-galactosyltransferase-expressing Allogeneic Renal Cell Carcinoma Vaccine
    69. Alpha-fetoprotein Peptide-Pulsed Autologous Dendritic Cell Vaccine
    70. alpha-Gal Epitope-Engineered MUC1-Expressing PANC1 Cell Vaccine
    71. Alpha-Galactosylceramide-Pulsed Autologous Dendritic Cells
    72. alpha-GalCer-AuNP-MUC1-Tn Vaccine
    73. Alpha-type-1 Polarized Dendritic Cells
    74. ALVAC gp100 Vaccine
    75. ALVAC Vaccine
    76. ALVAC(2) Melanoma Multi-antigen Vaccine
    77. ALVAC(2)-NY-ESO-1 (M)/TRICOM Vaccine
    78. ALVAC-B7-CEA
    79. ALVAC-CEA (6D)-B7.1 Vaccine
    80. ALVAC-CEA (VCP248)
    81. ALVAC-CEA B7.1 Vaccine
    82. ALVAC-CEA Vaccine
    83. ALVAC-ESO-1 Vaccine
    84. ALVAC-hB7.1
    85. ALVAC-MART-1 Vaccine
    86. ALVAC-P53 Vaccine
    87. AMHR2-ED
    88. AML mRNA Positive Lysate Loaded Autologous Dendritic Cell Vaccine
    89. Amolimogene Bepiplasmid
    90. Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118
    91. Ankara (MVA) and ALVAC(2) Vaccine
    92. Ankara (MVA) Vaccine
    93. Anti-CD19/CD3 Tetravalent Antibody AFM11 Vaccine
    94. Anti-CD3 x Anti-CD20 Bispecific Antibody-Armed Activated T Cells Cancer Vaccine
    95. Anti-CEA TCR Retroviral Vector-Transduced Autologous Peripheral Blood Lymphocytes
    96. Anti-CTLA4 MoAb RNA-transfected Autologous Dendritic Cell Vaccine
    97. Anti-CTLA4 MoAb RNA/GITRL RNA-transfected Autologous Dendritic Cell Vaccine
    98. Anti-GnRH Vaccine PEP223
    99. Anti-HER2/HER3 Dendritic Cell Vaccine
    100. Anti-idiotype MUC-1 Monoclonal Antibody Vaccine
    101. Anti-Idiotype Specified Monoclonal Antibody
    102. anti-idiotypic (anti-id) mAb MK2-23 + BCG
    103. Anti-idiotypic Monoclonal Antibody BEC2 Vaccine
    104. Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A
    105. Anti-NY-ESO1 TCR-transduced Autologous CD62L+-derived T-Lymphocytes
    106. Anti-p53 T-Cell Receptor-Transduced Peripheral Blood Lymphocytes Vaccine
    107. Anti-PRAME Immunotherapeutic GSK2302032A Vaccine
    108. Antigen-CPP vaccine
    109. Antigen-targeted Personalized Breast Cancer Vaccine
    110. APC8015F
    111. Apoptotic Autologous Tumor Cells-pulsed Alpha-type-1 Polarized Dendritic Cells
    112. attenuated Listeria expressing cancer antigen vaccine
    113. AuNP-Conjugated Fluoroproline-Modified S-Linked Tn-MUC1 Glycopeptide Vaccine
    114. AuNP-MUC1-Tn Vaccine with (2S,3R)-3-hydroxynorvaline
    115. AUT-OV-ALVAC-hB7.1 Vaccine
    116. Autolgous DC Vaccine Pulsed with Autologous Tumor Homogenate for Metastatic RCC
    117. Autologous Ad-CD154-Transduced CLL B Cells
    118. Autologous Anti-gp100:154-162 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes
    119. Autologous Anti-MART-1 F5 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes
    120. Autologous Cancer Testis Antigen Specific Dendritic Cell Vaccine
    121. Autologous CD133-Positive BTSC mRNA-Pulsed Autologous Dendritic Cell Vaccine
    122. Autologous CD40L-expressing B-CLL Vaccine
    123. Autologous CLL Tumor Cell Vaccine
    124. Autologous CMV-pp65-flLAMP mRNA Loaded Dendritic Cell Vaccine
    125. Autologous Colorectal Tumor Antigen-pulsed Dendritic Cell Vaccine
    126. Autologous CT7/MAGE-A3/WT1 mRNA-Electroporated Langerhans-Type Dendritic Cells
    127. Autologous DC vaccine pulsed with Tn-MUC1 100-mer glycopeptide and KLH
    128. autologous dendritic cell vaccine (DCV)
    129. Autologous Dendritic Cell Vaccine ACT2001
    130. Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine)
    131. Autologous Dendritic Cell-Adenovirus CCL21 Vaccine
    132. Autologous Dendritic Cell-Adenovirus P53 Vaccine
    133. Autologous Dendritic Cell-Allogeneic Melanoma Tumor Cell Lysate Vaccine
    134. Autologous Dendritic Cell-Autologous Tumor mRNA-Human CD40L Vaccine
    135. Autologous Dendritic Cell-based Immunotherapeutic AV0113
    136. Autologous Dendritic Cell-Tumor Fusion Vaccine
    137. autologous dendritic cells (DCs)
    138. Autologous Dinitrophenyl Vaccine
    139. Autologous Dinitrophenyl-Modified Ovarian Cancer Vaccine
    140. Autologous EBV-Transformed B Lymphoblastoid-Tumor Fusion Cell Vaccine
    141. Autologous Epstein-Barr Virus-Transformed B-Lymphoblastoid Cell Vaccine
    142. Autologous Expanded Mesenchymal Stem Cells OTI-010
    143. Autologous GM-CSF-Secreting Breast Cancer Vaccine
    144. Autologous GM-CSF-secreting Lethally Irradiated Colorectal Cancer Cell Vaccine
    145. Autologous GM-CSF-Secreting Lethally Irradiated Leukemia Cell Vaccine
    146. Autologous Heat-Shock Protein 70 Peptide Vaccine AG-858
    147. Autologous HNSCC DNA-transfected Semi-allogeneic Fibroblasts MRC-5 Vaccine
    148. Autologous IL-2-expressing B-CLL Vaccine
    149. Autologous Immunoglobulin Idiotype-KLH Conjugate Vaccine
    150. Autologous Lymphoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine
    151. Autologous Lymphoma Cell/Allogeneic Dendritic Cell Electrofusion Hybrid Vaccine
    152. Autologous Lymphoma Cell/Autologous Dendritic Cell Electrofusion Hybrid Vaccine
    153. Autologous Lymphoma Immunoglobulin-derived scFv-chemokine DNA Vaccine
    154. Autologous Melanoma Lysate-Pulsed Autologous Dendritic Cell Vaccine
    155. Autologous Melanoma Lysate/KLH-Pulsed Autologous Dendritic Cell Vaccine
    156. Autologous Melanoma Lysate/NY-ESO-1-pulsed Autologous Dendritic Cell Vaccine
    157. Autologous monocyte-derived mature DCs pulsed with p53, survivin and telomerase-derived peptides
    158. Autologous MUC1 peptide-pulsed DC vaccine
    159. Autologous Neuroblastoma Vaccine
    160. Autologous NSCLC DNA-Transfected Semi-Allogeneic Fibroblasts MRC-5 Vaccine
    161. Autologous NSCLC Peptide-specific Dendritic Cell Vaccine
    162. Autologous OFA-iLRP RNA-Transfected Dendritic Cell Vaccine
    163. Autologous Ovarian Tumor Cell Lysate-Pulsed Dendritic Cell Vaccine
    164. Autologous Oxidized Ovarian Tumor Cell Lysate Vaccine
    165. Autologous Pluripotent ALDHbr Stem Cells ALD-451
    166. Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101
    167. Autologous Renal Cell Carcinoma Tumor Lysate-Pulsed Dendritic Cell Vaccine
    168. Autologous Sarcoma Lysate-pulsed Dendritic Cell Vaccine
    169. Autologous TARP Peptide-Pulsed Dendritic Cell Vaccine
    170. Autologous Total Tumor mRNA and CMV-pp65-flLAMP mRNA Loaded Liposome Vaccine
    171. Autologous TriMix-DC Melanoma Vaccine
    172. Autologous tumor cell lysate vaccine
    173. Autologous Tumor Cell Proteoliposome Chronic Lymphocytic Leukemia Vaccine
    174. Autologous Tumor Cell Vaccine
    175. Autologous Tumor-associated Peptide Antigen-pulsed Dendritic Cell Vaccine
    176. Autologous, DNP-Modified Ovarian Cancer Vaccine
    177. Autologous-Cell Leukemia Vaccine
    178. Autologous-Cell Melanoma Vaccine
    179. B-cell lymphoma DNA vaccine VCL-1642.XXX encoding a chimeric immunoglobulin molecule onsisting of tumor-specific variable (Id) regions
    180. B16 melanoma DNA vaccine pCMV-hTRP-1 encoding TRP-1
    181. B16 melanoma DNA vaccine pSin-hTRP-1 encoding TRP-1
    182. B16 melanoma DNA vaccine pSin-mTRP-1
    183. B16 Vaccine adjuvanted by Loxoribine
    184. B7.1/​IL-2 Leukaemia Cell Vaccine
    185. Bacille Calmette Guérin for melanoma of lower extremity
    186. Bacillus Calmette-Guerin (BCG)
    187. Bacillus Calmette-Guerin (BCG), C. parvum
    188. Bacillus Calmette-Guerin (BCG), dinitrochlorobenzene (DNCB)
    189. bacillus Calmette-Guerin (MER)
    190. BC-819
    191. BCG
    192. BCG and chemotherapy for malignant melanoma
    193. BCG and Corynebacterium parvum for malignant melanoma
    194. BCG for melanoma
    195. BCG HSP65-MUC1 Fusion Protein Vaccine
    196. BCG treatment after surgical tumor removal
    197. BCG, Cell Wall Skeleton
    198. Bcl-Xl_42-CAF09b Vaccine
    199. Bcl-Xs Adenovirus Vaccine
    200. Bcr-Abl (b2a2)-Derived Peptide Vaccine
    201. Bcr-Abl (b3a2)-Derived Peptide Vaccine
    202. Bcr-abl peptide vaccine
    203. Belagenpumatucel-L
    204. Berzofsky Ras/P53 Peptide Vaccine
    205. Biolistic DNA vaccination
    206. Bivalent Vaccine with Adjuvant OPT-821
    207. BLP25 liposomal vaccine (L-BLP25/tecemotide/Stimuvax®)
    208. Brachyury-expressing Modified Vaccinia Ankara-TRICOM Vaccine
    209. Brain Tumor Initiating Cell Vaccine
    210. BSA-MUC1-TLR7a/Alum Binary Adjuvant Vaccine
    211. C29561
    212. Canarypox-hIL-12 Melanoma Vaccine
    213. Cancer DNA Vaccine encoding Endoglin Boosted with Recombinant Endoglin Protein
    214. Cancer DNA Vaccine encoding TEM8
    215. Cancer DNA Vaccine MIDGE/hNIS encoding hNIS protein
    216. Cancer DNA vaccine p.DOM-AH1 encoding fragment C
    217. Cancer DNA Vaccine pLXSHDmB7-2 encoding Cd86
    218. Cancer DNA Vaccine pSURV encoding Survivin
    219. Cancer EPCAM protein vaccine
    220. Cancer Her-2/neu Protein Subunit Vaccine
    221. Cancer recombinant vector vaccine encoding H-2Kb
    222. Cancer Retroviral Vector Vaccine encoding Cd40lg
    223. Cancer Stem Cell DC Vaccine
    224. Cancer Subunit DC (Tat-CEA) vaccine
    225. Cancer Subunit GV1001 Protein Vaccine
    226. Cancer Subunit NY-ESO-1 Protein Vaccine
    227. Cancer Vaccine using E7 protein of human papillomavirus 16 and Algammulin
    228. Cancer Vaccine using E7 protein of human papillomavirus 16 and Quil-A
    229. Cancer VEGFA protein vaccine
    230. Canvaxin
    231. CAP-2 (CEA Peptide 9-mer)
    232. CAP-3 (CEA Peptide 9-mer)
    233. CAR G36-PDL1
    234. Carcinoembryonic Antigen Peptide 1-6D
    235. Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine
    236. Carcinoembryonic Antigen Peptide-1 Vaccine
    237. Carcinoembryonic Antigen RNA-pulsed DC Cancer Vaccine
    238. Carcinoma DNA vaccine pVAX/E2A
    239. CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
    240. CD133 Antigen Peptide-pulsed Autologous Dendritic Cell Vaccine
    241. CD80 Breast Cancer Vaccine
    242. CDX-1307 Vaccine
    243. CEA RNA-pulsed Autologous Human Cultured Dendritic Cells
    244. CEA/Tetanus Toxoid T Helper Epitope Fusion Protein-Expressing DNA Plasmid Vaccine
    245. Chimeric Ad11p/Ad3 Oncolytic Virus
    246. Chimeric exosomal tumor vaccine
    247. Class I HLA-A*0201-restricted gp100209-2M peptide vaccine
    248. CLL Idiotypic DNA Vaccine
    249. CMV pp65 Peptide-pulsed Autologous Dendritic Cell Vaccine
    250. CMVpp65/gB Plasmid Vaccine ASP0113
    251. Colorectal cancer DNA vaccine pCEA/HBsAg encoding carcinoembryonic antigen and hepatitis B surface antigen
    252. Contusugene ladenovec
    253. Corynebacterium parvum, DTIC
    254. CpG 7909/PF3512676
    255. CpG-containing double-cassette vector (CpDV) DNA vaccine co-expressing IL-2 and soluble PD-1/MUC1-survivin [CpDV-IL2-sPD1/MS]
    256. CpG-Loaded MUC1-Tn Glycopeptide/P2 Tetanus Epitope Conjugate Cationic Nanohydrogel Vaccine
    257. CRM197-tetraMUC1-Tn Conjugate Vaccine
    258. CTB-MUC1-Alum-CpG Vaccine
    259. CTP-37-DT Vaccine
    260. CVB4/p24(73(3))
    261. Cyclin B1 Peptide-pulsed Autologous Dendritic Cell Vaccine
    262. Cyclin B1/WT-1/CEF-Loaded DC Vaccine
    263. Cytokine-Induced Killer Cells
    264. DC Vaccine Transduced with Recombinant Ad5 with F35 Fiber Modification Encoding MUC1 cDNA (7VNTR) (rAd5F35-MUC1)
    265. DC/AML Fusion Vaccine
    266. Dendritic Cell Survivin Vaccine
    267. Dendritic Cell Tumor Cell Lysate Vaccine
    268. Dendritic Cell Tumor Peptide Vaccine
    269. Dendritic Cell-Autologous Lung Tumor Vaccine
    270. Dendritic Cell-CEA Peptide Vaccine
    271. Dendritic Cell-gp100-MART-1 Antigen Vaccine
    272. Dendritic Cell-Idiotype-Keyhole Limpet Hemocyanin Vaccine
    273. Dendritic Cell-MART-1 Peptide Vaccine
    274. Dendritic Cell-Recombinant Prostate-Specific Membrane Antigen Vaccine
    275. Dendritic Cell-targeting Lentiviral Vector ID-LV305
    276. Dendritic Cell/​Myeloma Fusion Vaccine
    277. Dendritic vaccine, allogeneic hematopoietic stem cells, cytotoxic lymphocytes
    278. Dendritic vaccine, autologous hematopoietic stem cells, cytotoxic lymphocytes
    279. DEPDC1/MPHOSH1 Peptide Vaccine
    280. di-Man-MUC1-Tn-TTox Vaccine
    281. Dinitrophenyl-Modified Autologous Renal Cell Carcinoma Tumor cell Vaccine
    282. Dipalmitoyl-MUC1/DDA/MPLA Liposomal Vaccine
    283. DIPG and GMB Immunomodulatory DC Vaccine
    284. DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine
    285. DNA Plasmid Encoding Interleukin-12 INO-9012
    286. DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112
    287. DNA Vaccine encoding p42.3
    288. DNA Vaccine VB10.16
    289. DNA Vector pPRA-PSM Vaccine
    290. DNP-modified autologous vaccine
    291. E1M(184V) Peptide Vaccine
    292. EF-1 Peptide Vaccine
    293. EF-2 Peptide Vaccine
    294. EGFRvIII Peptide Vaccine
    295. Electrofusion DC vaccine
    296. electroloading of mature dendritic cells with melanoma whole tumor cell lysate
    297. Emepepimut-S Vaccine
    298. EP-2101 Vaccine
    299. ESAT-6-gpi DNA vaccine combined with B16F10-ESAT-6-gpi/IL-21 vaccine
    300. ESO-1 (161-180) Peptide Vaccine
    301. ESO-1 Reactive Autologous Peripheral Blood Lymphocyte Vaccine
    302. ESO-1:157-165(165V) Peptide Vaccine
    303. ESR1 peptide vaccine
    304. F2T-antigen-MUC1-TTox vaccine
    305. Falimarev Vaccine
    306. Fas-Chimera Transgene-expressing Endothelial Tumor Cell-targeting Adenovector VB-111 Vaccine
    307. Flagrp170
    308. Folate-FITC Vaccine
    309. Follicular lymphoma, patient-specific, soluble protein idiotype vaccine
    310. Four-Component MUC1-diTn Conjugate Vaccine with Three T-Helper Epitopes
    311. Fowlpox Virus Vaccine
    312. Fowlpox Virus Vaccine Vector
    313. Fowlpox-NY-ESO-1 Vaccine
    314. Fowlpox-PSA-TRICOM Vaccine
    315. FRAME-001 personalized vaccine
    316. FrSh61 (MEA) VHL33 Peptide Vaccine
    317. FVAX
    318. G250 Peptide Vaccine
    319. Gag:267-274 Peptide Vaccine
    320. GD2-CAR
    321. GD2L, GD3L, Globo H, fucosyl GM1, and N-propionylated polysialic acid KLH Conjugate Vaccine
    322. Genetically Engineered Allogeneic Prostate Carinoma Cells Secreting Interleukin-2 and Interferon Gamma
    323. GITRL RNA-transfected Autologous Dendritic Cell Vaccine
    324. Glioma-Associated Antigen Peptide-Pulsed Autologous Dendritic Cell Vaccine
    325. Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701
    326. Globo H-DT Vaccine OBI-833
    327. Globo H-GM2-Lewis-y-MUC1-32-mer-TF(c)-Tn(c)-KLH Conjugate Vaccine
    328. Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH Conjugate Vaccine
    329. Glypican-3-derived peptide vaccine for human hepatocellular carcinoma
    330. GM-CSF transfected cells vaccine
    331. GM-CSF, IL-12 and GM-CSF+IL-12 genetically modified tumor cell vaccine
    332. GM-CSF-encoding Oncolytic Adenovirus CGTG-102 Vaccine
    333. GM-K562 cell vaccine
    334. GM.CD40L Cell Vaccine
    335. GM2/GD2/GD3 Lactone-KLH Conjugate Trivalent Vaccine
    336. Golnerminogene Pradenovec Vaccine
    337. gp100 + Mart-1 + Mart-3 Vaccine
    338. gp100 Adenovirus Vaccine
    339. gp100 and GM-CSF DNA/Gold Vaccine
    340. gp100 mature dendritic cell vaccine
    341. gp100 Protein (184V) Vaccine
    342. gp100 Vaccine
    343. gp100 Vaccinia Vaccine
    344. gp100-Fowlpox Vaccine
    345. gp100-Pulsed Peripheral Blood Mononuclear Cell Vaccine
    346. gp100-Reactive Autologous Peripheral Blood Lymphocyte Vaccine
    347. gp100/IFA Vaccine
    348. gp100: ES209-217(210M) Peptide Vaccine
    349. gp100:154-162 Peptide Vaccine
    350. gp100:209-217 Peptide Vaccine
    351. gp100:209-217(210M) peptide vaccine
    352. gp100:280-288 Peptide Vaccine
    353. gp100:280-288(288V) Peptide Vaccine
    354. gp96-secreting Allogeneic Bladder Cancer Cell Vaccine HS-410
    355. GVAX Cancer Vaccine
    356. GVAX Leukemia Vaccine
    357. GVAX Lung Cancer Vaccine
    358. GVAX Pancreatic Cancer Vaccine
    359. H3.3K27M-specific Peptide Vaccine
    360. hapten dinitrophenyl
    361. HCA587 protein vaccine
    362. HCV DNA Vaccine INO-8000
    363. HER-2-neu, CEA peptides, GM-CSF, Montanide ISA-51 vaccine
    364. HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901
    365. HER2 ICD peptide vaccine
    366. HER2-pulsed Autologous Type-1 Polarized Dendritic Cell Vaccine
    367. Heterologous DNA Prime/rMVA Boost Vaccine Co-targeting MUC1 and Survivin Combined with Metformin [3D/M+Met]
    368. Hexapeptide melanoma vaccine
    369. HLA Neoantigen Vaccine
    370. HLA-A*0201-Restricted TRP2-gp100-EphA2-HER2 multipeptide Vaccine
    371. HLA-A*0201-Restricted URLC10-VEGFR1-VEGFR2 Multipeptide Vaccine
    372. HLA-A*0201-Restricted VEGFR1 Peptide Vaccine
    373. HLA-A*2402-Restricted VEGFR1 Peptide Vaccine
    374. HLA-A*2402-Restricted VEGFR1/2 Multipeptide Vaccine
    375. HLA-A*2404-Restricted RNF43-TOMM34-VEGFR1-VEGFR2 Multipeptide Vaccine
    376. HLA-A1, A2, B35-Restricted Survivin Peptides/Montanide ISA-51 Vaccine
    377. HLA-A1, HLA-A2, and CD40-Ligand Pulsed Dendritic Cell Vaccine
    378. HLA-A1-Binding MAGE-1/MAGE-3 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine
    379. HLA-A2, A3-Restricted FGF-5 Peptides/Montanide ISA-51 Vaccine
    380. HLA-A2-Binding TYR/MART-1/gp100 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine
    381. HLA-A2-Restricted Synthetic Glioma Antigen Peptides Vaccine
    382. HLA-Matched Donor Mononuclear Cell-Enriched Leukocytes Apocell Vaccine
    383. hMART-IT
    384. Hodgkin's antigens-GM-CSF-expressing cell vaccine
    385. Host Dendritic Cell Vaccine-001 MSSM/BIIR
    386. HPV 16 E6 (18-26) Peptide Vaccine
    387. HPV 16 E7:12-20 Peptide Vaccine
    388. HPV 16 E7:86-93 Peptide Vaccine
    389. HPV 16 L1-VLP Vaccine
    390. HPV 18 E6:13-21 Peptide Vaccine
    391. HPV 18 L1-VLP Vaccine
    392. HPV DNA Plasmids Therapeutic Vaccine VGX-3100
    393. HPV E6/E7 DNA Vaccine GX-188E
    394. HPV E6/E7-encoding Semliki Forest Virus Vaccine Vvax001
    395. HPV-11 Vaccine
    396. HPV-6-targeting Immunotherapeutic Vaccine INO-3106
    397. HPV16 E6/E7 Melanoma Vaccine
    398. HSP65-HER2 fusion peptide
    399. Hsp70 chaperone-based gel composition
    400. HSPPC-96
    401. hTERT I540/R572Y/D988Y Multipeptide Vaccine
    402. hTERT mRNA/Survivin Peptide-double-loaded Autologous Dendritic Cell Vaccine
    403. hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301
    404. hTERT Vaccine V934/V935
    405. hTERT-LAMP mRNA-loaded Autologous Dendritic Cell Vaccine GRNVAC1
    406. hTERT/Survivin/CMV Multipeptide Vaccine
    407. hTERT/Survivin/Melanoma Tumor Cell-Derived mRNA-Transfected Dendritic Cell Vaccine
    408. hu(TA)MUC1 Glycopeptide (STn-T3/Tn-T16)–TTox Conjugate Vaccine
    409. human leukocyte antigen class I-modified peptides
    410. Human Myeloid Progenitor Cells CLT-008 Vaccine
    411. Human Papilloma Virus L1 Virus-Like Particle V504 Vaccine
    412. Human Papillomavirus 16 E7 Peptide/Padre 965.10 Vaccine
    413. Human Papillomavirus 16/18 L1 Virus-Like Particle/AS04 Vaccine
    414. Human Papillomavirus Tumor Antigen Vaccine
    415. Human Papillomavirus Vaccine V503
    416. Human Prostate-Specific Membrane Antigen Plasmid DNA Vaccine
    417. HUVECs-OK432 vaccine
    418. hVEGF26-104/RFASE Peptide Vaccine
    419. Hybrid Membrane Vesicle (MV) Vaccine: Pam₂-MUC1 + Autologous Membrane Proteins
    420. HyperAcute - Breast cancer vaccine
    421. HyperAcute-Melanoma Vaccine
    422. HyperAcute-Prostate Cancer Vaccine
    423. Hyperbranched Polyglycerol (HPG)-MUC1 dual-Tn glycopeptide–P2 vaccine
    424. ICT-121 Dendritic Cell Vaccine
    425. IDD-3
    426. IDH1R132H Mutation-targeting IDH1 Peptide Vaccine
    427. IDH1R132H-Specific Peptide Vaccine PEPIDH1M
    428. Idiotype-Pulsed Autologous Dendritic Cell Vaccine APC8020
    429. IDO peptide vaccine
    430. IFN/tremem
    431. IgG3-Fc-Conjugated Liposomal Pam3CysSK4-MUC1-Tn Vaccine
    432. IL-12-expressing Mesenchymal Stem Cell Vaccine GX-051
    433. IL-12p70
    434. IL-2, Peptide, and GM-CSF-in-adjuvant Melanoma Vaccine
    435. IL-2/Lptn Gene-Modified Allogeneic Neuroblastoma Tumor Cell Vaccine
    436. IL15-DC Vaccine
    437. IMM-101
    438. ImMucin (MUC1-SP) Vaccine
    439. Immunotherapeutic GSK1572932A
    440. IMT-1012 Immunotherapeutic Vaccine
    441. Inactivated Vaccinia Virus
    442. Inalimarev Vaccine
    443. Incomplete Freund's adjuvant (IFA) alone, or a melanoma vaccine in IFA
    444. Indium In 111-Labeled Autologous Peripheral Blood Mononuclear Cells Vaccine
    445. Indium In 111-Labeled Autologous Polymorphonuclear Leukocytes Vaccine
    446. Indoleamine 2,3-dioxygenase Peptide Vaccine
    447. Interferon-gamma-expressing Adenovirus Vaccine ASN-002
    448. Interleukin-2 Anti-Idiotype Vaccine
    449. Intracel KLH Vaccine
    450. intralesional bacile Calmette-Guérin (BCG)
    451. intralesional bacile Calmette-Guérin (BCG), DTIC, vincristine
    452. Ipilimumab
    453. Ipilimumab
    454. ipilimumab, vemurafenib
    455. irradiated autologous cells
    456. irradiated melanoma cells plus BCG
    457. α-GalCer-loaded tumor-cell vaccine
    458. KLH and Tumor Lysate Pulsed DC Vaccine
    459. KLH-FITC Vaccine
    460. KLH-id Vaccine
    461. KLH-Lymphoma Ig Vaccine
    462. KLH-pulsed autologous dendritic cell vaccine
    463. KRAS-targeted mRNA vaccine
    464. KSA-KLH Conjugate Vaccine
    465. L612 HuMAb
    466. Lapuleucel-T Vaccine
    467. Large Multivalent Immunogen (LMI) vaccine
    468. Leukemic Apoptotic Corpse-Pulsed Autologous Dendritic Cells Vaccine
    469. Light-Emitting Oncolytic Vaccinia Virus GL-ONC1 Vaccine
    470. Linear Trivalent MUC1 PDT(Tn)RPAP-BSA Conjugate Vaccine
    471. Liposomal Diphtheria Toxoid331-345 Epitope-MUC1 Glycopeptide Vaccine with alpha-GalCer
    472. Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
    473. Liposomal Pam2-MUC1-Tn Vaccine with alpha-GalCer
    474. Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809
    475. Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809 Vaccine
    476. Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623
    477. LMP-2:340-349 Peptide Vaccine
    478. LMP-2:419-427 Peptide Vaccine
    479. LMP2A-loaded conventional DC vaccine
    480. Long Peptide Vaccine 7
    481. long-peptide vaccine and mAb
    482. LY6K/VEGFR1/VEGFR2 Multipeptide Vaccine
    483. Lymphoma DNA vaccine VαVβVβ-FrC
    484. mAb PC61 and DC/tumor fusion
    485. MAGE-1 Vaccinia Contaminated with BVDV
    486. MAGE-3.A1 Peptide Vaccine
    487. MAGE-A1, Her-2/neu, FBP peptides ovarian cancer vaccine
    488. MAGE-A1/MAGE-A3/NY-ESO-1 Peptides Vaccine
    489. MAGE-A12:170-178
    490. MAGE-A3 + AS15
    491. MAGE-A3 Peptide Vaccine
    492. MAGE-A3-expressing Adenovirus Type 5 Vaccine
    493. MAGE-A3-genetically modified lymphocytes
    494. MAGE-A3/HPV 16 Peptide Vaccine
    495. Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
    496. Mammaglobin-A DNA Vaccine
    497. Maraba virus MG1 Vaccine
    498. MART-1
    499. MART-1 Adenovirus Vaccine
    500. MART-1 Fowlpox Vaccine
    501. MART-1 Vaccinia Vaccine
    502. MART-1, tyrosinase and MAGE-A6 Autologous DC Vaccine
    503. MART-1/gp100/Tyrosinase/MAGE-A3 Peptides-loaded Irradiated Allogeneic Plasmacytoid Dendritic Cells Vaccine
    504. MART-1:26-35(27L) Peptide Vaccine
    505. MART-1:27-35 Peptide Vaccine
    506. Mature dendritic cell melanoma vaccine
    507. MCMV-TRP2
    508. mCRT-vGPCR-coated whole-cell vaccine
    509. MDX-1379 (gp100) Melanoma Peptide Vaccine
    510. MDX-CTLA4 Antibody/Tyrosinase/gp100/MART-1 Melanoma Vaccine
    511. Melacine
    512. Melan-A VLP Vaccine
    513. Melan-A/MAGE-3.DP4 Peptide Vaccine
    514. Melan-A/Mart-1
    515. Melanoma DNA vaccine gp75 DNA encoding melanosomal membrane glycoproteins, gp75
    516. Melanoma DNA vaccine hTRP2 encoding TRP-2
    517. Melanoma DNA vaccine hugp100 encoding gp100
    518. Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP
    519. Melanoma DNA vaccine pN4a-MAGE-1-GM
    520. Melanoma DNA vaccine pNL3-MAGE-1-GM
    521. Melanoma DNA vaccine pUB-TRP-2 encoding a fusion protein linking murine ubiquitin (UB) to the N-terminus of the full-length mTRP-2
    522. Melanoma DNA vaccine SINCp c-muMUC18 encoding MCAM/MUC18
    523. Melanoma DNA vaccine TA2Mâ„¢ encoding tyrosinase peptides
    524. Melanoma DNA vaccine VR-S8/VR-IL2/AD-S8 encoding survivin
    525. Melanoma DNA vaccine VR1012/mPmel17
    526. Melanoma DNA vaccine xenogeneic DNA encoding murine tyrosinase
    527. melanoma helper peptide vaccine
    528. Melanoma recombinant vector vaccine rVVmTRP-1 encoding TRP-1
    529. Melanoma Theraccine
    530. Melanoma-specific Melan-A/Mart-1 peptide + virus-like nanoparticles
    531. Melapuldencel-T Vaccine
    532. MELITAC 12.1 Peptide Vaccine
    533. Mesothelioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
    534. Methanol Extraction Residue of BCG
    535. MF59-YW002/HSP65-MUC1 Recombinant Fusion Protein Vaccine
    536. MF59/CpG ODN1826-adjuvanted MUC1-Maltose Binding Protein (MBP) Vaccine
    537. MG1-hDCT Vaccine
    538. MiHA-loaded PD-L1/L2-silenced Dendritic Cell Vaccine
    539. Mimotope-P10s-PADRE Peptide Vaccine
    540. Mixed bacterial vaccine
    541. Modified Vaccinia Ankara (Bavarian Nordic)-HER2 Vaccine
    542. Modified Vaccinia Virus Ankara Vaccine Expressing p53
    543. Monoclonal Antibody 105AD7 Anti-idiotype Vaccine
    544. Monoclonal Antibody 11D10 Anti-Idiotype Vaccine
    545. Monoclonal Antibody 3H1 Anti-Idiotype Vaccine
    546. Monoclonal Antibody 4B5 Anti-Idiotype Vaccine
    547. Monoclonal Antibody A1G4 Anti-Idiotype Vaccine
    548. Monoclonal Antibody GD2 Anti-Idiotype Vaccine
    549. Montanide ISA-51/Survivin Peptide Vaccine
    550. Mouse gp100 Plasmid DNA Vaccine
    551. Mouse Prostate-Specific Membrane Antigen Plasmid DNA Vaccine
    552. mouse/human gp10025-33 peptide plus CpG adjuvant; mouse/human gp100; mouse/human gp10025-33 peptide-pulsed DCs
    553. MOv-PBL Vaccine
    554. mRNA neoantigen tumor vaccine
    555. mRNA tumor antigen DC vaccine
    556. mRNA-based Personalized Cancer Vaccine NCI-4650
    557. mRNA-Derived Prostate Cancer Vaccine CV9103
    558. mRNA-electroporated dendritic cells encoding gp100 and tyrosinase as melanoma vaccine
    559. MSCV-MGMT(P140K) Vaccine
    560. MT-201-GBM monocyte vaccine
    561. MUC-1 Peptide Vaccine
    562. MUC-2-Globo H-KLH Conjugate Vaccine
    563. MUC-2-KLH Vaccine
    564. MUC1 (144-173)-loaded umbilical cord blood-derived mature DC vaccine
    565. MUC1 (Glyco)peptide Vaccine: KLH/MAP-4/chimeric
    566. MUC1 100-mer peptide vaccine with MPLA, R848, and CpG 1826 encapsulated in C3-targeting liposomes
    567. MUC1 100-mer Peptide-Pulsed Autologous DC Vaccine
    568. MUC1 100mer Peptide Vaccine with SB-AS2
    569. MUC1 105mer Peptide/BCG Vaccine
    570. MUC1 12-mer–STn(T3)–OVA₃₂₃₋₃₃₉ Glycopeptide Conjugate Vaccine
    571. MUC1 140-mer Peptide-Pulsed DC Vaccine ± Soluble MUC1 140-mer Peptide
    572. MUC1 140mer Peptide Vaccine with GM-CSF or SB-AS2
    573. MUC1 22-mer Peptide Vaccines (APG, SAP) with CpG 1826/IFA
    574. MUC1 24-mer Peptide-Loaded PLGA Microsphere Vaccine
    575. MUC1 60-mer Tn/STn Glycopeptide-KLH Conjugate Vaccine
    576. MUC1 9mer (Glyco)peptide Vaccines (APG, SAP, APG-Tn, SAP-Tn)
    577. MUC1 9VNTR Adenoviral Vector Prime Protein Boost (VPP) Vaccine
    578. MUC1 beta-GalNAc-Thr Glycopeptide-BSA Vaccine
    579. MUC1 cDNA-transfected autologous DC vaccine
    580. MUC1 Engineered Membrane Vesicle (E-MV) Vaccine
    581. MUC1 mRNA/CTLA-4 siRNA Co-Delivery Mannose-Modified NLE Vaccine
    582. MUC1 Peptide-Poly-ICLC Vaccine
    583. MUC1 Rotating Tumor Lysate Vaccines (C57mg, KCM, EL4, B16)
    584. MUC1 Single Tandem Repeat GPI-anchored mRNA Vaccine [MUC1(1TR)-CD24]
    585. MUC1 Tn/T-T9 Glycopeptide-BSA Conjugate Vaccine
    586. MUC1 VNTR-Q11 Self-Adjuvanting Tn-Glycopeptide Vaccines
    587. MUC1(16-mer)-KLH vaccine [BP16-KLH]
    588. MUC1(T-antigen)-Pam3CSK4 lipoglycopeptide vaccine
    589. MUC1(Tn)/MUC1(STn)/MUC1(2,3-ST)–TT Mosaic Glycopeptide Vaccine
    590. MUC1-HSP70 Chimeric DNA vaccine
    591. MUC1-KLH + GD3-KLH Conjugate Vaccine with Adjuvants (QS-21+CpG/GPI-0100)
    592. MUC1-KLH Vaccine/QS21
    593. MUC1-KLH/DHBcAg conjugate vaccine
    594. MUC1-MALP2 (Pam₂Cys) Conjugate Vaccines (unglycosylated/Tn/T)
    595. MUC1-maltose-binding protein (MBP)/BCG vaccine
    596. MUC1-MPA11P-Pulsed DC Vaccine
    597. MUC1-mRNA DC Vaccine and MUC1-CTLs plus Gemcitabine
    598. MUC1-Overexpressing CD133+ Colorectal Cancer Stem Cell Lysate Vaccine
    599. MUC1-pcDNA3.1-2-VNTR Vaccine
    600. MUC1-PD-L1-T helper epitope-IgG1 Fc Fusion Protein-Loaded DC Vaccine
    601. MUC1-STn(T6)-OVA323-339 vaccine
    602. MUC1-STn/Tn glycopeptide-poliovirus T-helper epitope-Pam3CysSK4 vaccine
    603. MUC1-targeted Peptide GO-203-2C Vaccine
    604. MUC1-Tn alpha/beta-Glycopeptide AuNP Vaccine
    605. MUC1-Tn(T9,S15,T16)-Pam3CSK4-P30 Trivalent/Monovalent Vaccine
    606. MUC1-Tn-alpha-MeSer-Pam2Cys Liposomal Vaccine
    607. MUC1-Tn-DC-Derived Exosome (Dex) Conjugate Vaccine
    608. MUC1-Tn-Pam3CysSK4 glycopeptide tripartite vaccine
    609. MUC1-Tn/gamma-PGA Multilayer Self-Assembly Nanovaccine
    610. MUC1-Tn–P30–AuNP Three-Component Vaccine
    611. MUC1-Tn–TT epitope–FSL-1 tricomponent vaccine
    612. MUC1-VNTR1 Peptides with Asn Substitutions at O-Glycosylation Sites: T3N, T10,18N (PD Context) and T3,11,16N, S2,T3,11,S12,T16N (GS Context) Variants
    613. MUC1/survivin-pulsed, SOCS1-silenced, flagellin-stimulated autologous DC vaccine
    614. Multi-epitope Folate Receptor Alpha Peptide Vaccine
    615. Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
    616. Multi-epitope HER2 Peptide Vaccine TPIV100
    617. Multi-epitope melanoma peptide vaccine
    618. Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
    619. Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
    620. Multiantigen Liposome Loaded Dendritic Cell Vaccine
    621. Multipeptide melanoma vaccine
    622. Multipeptide Vaccine S-588210
    623. Multipeptide XS15 Vaccine
    624. Multiple Signals loaded Dendritic Cells Vaccine
    625. Multivalent immunotherapeutic vaccine
    626. Murine TYRP2 Plasmid DNA Vaccine
    627. Mutant p53 Peptide Pulsed Dendritic Cell Vaccine
    628. Mutant VEGF165b-MUC1 Fusion Protein Vaccine
    629. Mutated neopeptide vaccine
    630. MVA-BN-CV301
    631. MVA-EBNA1/LMP2 Vaccine
    632. MVA-FCU1 TG4023 Vaccine
    633. MVA-MUC1-IL2 Vaccine (TG4010)
    634. MVA-PSA/PAP Prostate Cancer Vaccine
    635. MVF-HER-2(597-626)/MVF-HER-2 (266-296) Peptide Vaccine
    636. MVF-HER-2(628-647)-CRL 1005 vaccine
    637. NA-17/MAGE-3.A2/NY-ESO-1 Peptide Vaccine
    638. NA17.A2 Peptide Vaccine
    639. Nap-G(D)F(D)F(D)Y(D)K-TSAPDT(Tn)RPAP Conjugate Vaccine
    640. Natural Killer Cells ZRx101 Vaccine
    641. Nelipepimut-S Plus GM-CSF Vaccine
    642. NEO-PV-01 vaccine
    643. Neoantigen DNA Vaccine
    644. Neoantigen Peptide Vaccine
    645. neoantigen synthetic long peptide vaccine
    646. Neoantigen-loaded Autologous Dendritic Cell Vaccine
    647. Neuroblastoma DNA vaccine HuDsec
    648. Newcastle disease virus lysate
    649. NY-ESO-1 Peptide Vaccine
    650. NY-ESO-1 Plasmid DNA Cancer Vaccine
    651. NY-ESO-1(157-165) Peptide-pulsed Autologous Dendritic Cell Vaccine
    652. NY-ESO-1, MAGE-A1, and MAGE-A3 Dendritic Cell Vaccine
    653. NY-ESO-1/GLA-SE Vaccine ID-G305AmN
    654. NY-ESO-1/LAGE-1 Peptide Vaccine
    655. NY-ESO-1/MART-1 Peptide-pulsed Dendritic Cell Vaccine
    656. NY-ESO-1/PRAME/MAGE-A3/WT-1 Peptide Vaccine
    657. NY-ESO-1b Peptide Vaccine
    658. NY-ESO-B Vaccine
    659. OCDC and NeoDC Vaccine
    660. Oncolytic Adenovirus Encoding GM-CSF Vaccine
    661. Oncovax-ID/IL-2 Vaccine
    662. ONYX-015 Vaccine
    663. Oral Bacille Calmette-Guérin for malignant melanoma
    664. Oral Cancer Vaccine V3-OVA
    665. Oral Therapeutic Vaccine V3-X
    666. OVA-TEXO
    667. Ovapuldencel-T Vaccine
    668. Ovarian Cancer Peptide Vaccine
    669. Ovarian Cancer Stem Cell/hTERT/Survivin mRNAs-loaded Autologous Dendritic Cell Vaccine
    670. Ovarian Tumor Antigen-activated Autologous Dendritic Cell Vaccine
    671. Oxidized Mannan-MUC1 Fusion Protein (M-FP) vaccine
    672. Oxidized mannan-MUC1 fusion protein (M-FP) vaccine ± GM-CSF+IL-7
    673. p.DOM-WT1-126 DNA Vaccine
    674. p.DOM-WT1-37 DNA Vaccine
    675. P30-linked EphA2/CMV pp65/Survivin Peptide Vaccine P30-EPS
    676. P501-AS15 vaccine
    677. p53 Peptide Vaccine
    678. P53-Synthetic Long Peptides Vaccine
    679. PA-1-STK Ovarian Carcinoma Vaccine
    680. PADRE-CMV Fusion Peptide Vaccine
    681. Pam3CSK4-BSA-MUC1 Liposome Vaccine
    682. Pam3CSK4-MUC1-(Rha)3 Liposomal Vaccine
    683. Pam3CysSK4–MUC1-Tn glycolipopeptide vaccine
    684. Pancreatic tumor personalized neoantigen vaccine
    685. PAX3/FKHR Peptide Vaccine
    686. pcDNA3-hMUC1 DNA Vaccine
    687. pcDNA3-MCC/ST
    688. pcDNA3.1-MUC1 plasmid vaccine
    689. pcDNA3.1-VNTR MUC1 DNA Vaccine
    690. pcDNA3/hMUC1 DNA Vaccine Combined with mANT2 shRNA-1
    691. pCEP4-MUC1 cDNA Plasmid DNA Vaccine
    692. PCLUS 3-18MN Vaccine
    693. PCLUS 6.1-18MN Vaccine
    694. pCR3.1-VS-HSP65-TP-GRP6-M2
    695. PD-L1 peptide vaccine
    696. PD-L1/IDO Peptide Vaccine IO102-103
    697. PDTRP-MUC1-Calix[4,8]arene-Pam₃Cys-Ser Self-Adjuvant Vaccines (Tetravalent and Octavalent)
    698. PEP-3-KLH Conjugate Vaccine
    699. PEP-CMV Vaccine
    700. Personal neoantigen cancer vaccine
    701. Personalized follicular lymphoma vaccine
    702. Personalized mature dendritic cell vaccine
    703. Personalized NeoAntigen Melanoma Vaccine
    704. Personalized Synthetic Long Peptide Breast Cancer Vaccine
    705. Pexastimogene-devacirepvec Vaccine
    706. PF-04948568 Vaccine
    707. Plant-Expressed Hydroxyproline (Hyp) Tri-Arabinan (Ara₃)-Glycosylated Heat-Labile Enterotoxin B Subunit (LTB)–MUC1 Vaccine with CpG 1826
    708. Plasmacytoid Dendritic Cell Vaccine
    709. pMUC1/pmuIL-18 DNA Vaccine
    710. pNGVL3-hICD Vaccine
    711. pNGVL4a-CRT/E7(detox) DNA Vaccine
    712. pNGVL4a-Sig/E7(detox)/HSP70 DNA Vaccine
    713. Poliovirus T-Helper Epitope (PV103-115)-keto-Echinocystic Acid (kEA) Saponin–MUC1 Tricomponent Peptide Vaccine
    714. Poliovirus vector expressing model antigen H2-Kb-restricted CTL epitope
    715. Poly Microsphere Encapsulated HER2/neu Oral Vaccine
    716. Poly(HPMA)-MUC1(Tn)-TT P2-b-Poly(LMA) Conjugate Vaccine
    717. PolyPEPI1018 CRC Vaccine
    718. Polyvalent melanoma vaccine
    719. PR-151 Peptide Vaccine
    720. PR1 Leukemia Peptide Vaccine
    721. Primary Prostate Cancer Tissue/hTERT/Survivin mRNA-loaded Autologous Dendritic Cell Vaccine
    722. prime/boost DC-TRP-2 melanoma vaccine
    723. procarbazine, dactinomycin, velba
    724. Prodencel
    725. Prostate cancer DNA vaccine encoding PSCA
    726. Prostate cancer DNA vaccine hPSMAt encoding PSMA
    727. Prostate cancer DNA vaccine pcDNA3-STEAP encoding six-transmembrane epithelial antigen
    728. Prostate cancer DNA vaccine pDOM-PSMA27 encoding PSMA
    729. Prostate cancer DNA vaccine pmPSCA encoding PSCA
    730. Prostate cancer DNA vaccine PSCA-HSP encoding PSCA and HSP
    731. Prostate cancer DNA vaccine psig-3P-Fc encoding 3P(hPSM, hPAP, or hPSA)-Fc fusion protein
    732. Prostate cancer DNA vaccine pVax-PSA
    733. Prostate cancer DNA vaccine rPSMAt encoding PSMA
    734. Prostate Cancer Vaccine ONY-P1
    735. Prostate Tumor Antigen-activated Autologous Dendritic Cell Vaccine
    736. PROSTVAC-Contaminated W/ BVDV
    737. PSA Prostate Cancer Vaccine
    738. PSA RNA-Pulsed Dendritic Cell Vaccine
    739. PSA-OP Peptide Vaccine
    740. PSA-PAP/KLH-pulsed Autologous Dendritic Cell Vaccine
    741. PSA/IL-2/GM-CSF Vaccine
    742. PSA/PSMA DNA Plasmid INO-5150 Vaccine
    743. PSA:154-163 Peptide Vaccine
    744. PSA:154-163(155L) Peptide Vaccine
    745. PSMA/TARP Peptide Vaccine
    746. pTVG-HP Plasmid DNA Vaccine
    747. Pulmonary BCG immunotherapy for malignant melanoma
    748. pUMVC3-hIGFBP-2 Multi-Epitope Plasmid DNA Vaccine
    749. pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
    750. pVAX1-MUC1-6VNTR DNA Vaccine with C-terminal PDTRP Positioning
    751. pVAXrcPSAv53l DNA Vaccine
    752. QS-21-Derived Saponin–Poliovirus T-Helper Epitope–(Tn)MUC1 (Glyco)peptide Tricomponent Vaccine
    753. Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine
    754. Qβ-MUC1 SAPDT(Tn)RPAP Conjugate Vaccine
    755. Qβ-MUC1-Tf/STn Vaccine
    756. Qβ-MUC1-β-Tf Conjugate Vaccine
    757. Racotumomab Vaccine
    758. RAS Peptide Cancer Vaccine
    759. RAS Peptide Cancer Vaccine TG01
    760. RASVAC-C Vaccine
    761. RASVAC-V Vaccine
    762. RCAS-Akt Vaccine
    763. RCAS-Ras Vaccine
    764. Recombinant Adenovirus 5 Encoding Tumor Necrosis Factor-related Apoptosis-Inducing Ligand Vaccine
    765. Recombinant Adenovirus-Cre Recombinase Vaccine
    766. Recombinant Adenovirus-hIFN-beta Vaccine
    767. Recombinant Adenovirus-Interferon/Syn3 Vaccine
    768. Recombinant Adenovirus-L523S Vaccine
    769. Recombinant Adenovirus-LacZ Vaccine
    770. Recombinant Adenovirus-p53 SCH-58500 Vaccine
    771. Recombinant Anti-WT1 Immunotherapeutic GSK2302024A Vaccine
    772. Recombinant Colorectal cancer antigen GA733 Vaccine
    773. Recombinant dHER2 Vaccine
    774. Recombinant DNA-L523S Vaccine
    775. Recombinant Fowlpox GM-CSF Vaccine Adjuvant
    776. Recombinant Fowlpox-B7.1 Vaccine
    777. Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine
    778. Recombinant Fowlpox-gp100p209 Vaccine
    779. Recombinant Fowlpox-Mgp100 Vaccine
    780. Recombinant Fowlpox-Prostate Specific Antigen Vaccine
    781. Recombinant Fowlpox-PSA(L155)/TRICOM Vaccine
    782. Recombinant Fowlpox-TRICOM Vaccine
    783. Recombinant Fowlpox-Tyrosinase Vaccine
    784. Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
    785. Recombinant Human Fusion Protein L19TNFalpha Vaccine
    786. Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
    787. Recombinant Human MUC1-Oxidized Polymannose-pulsed Autologous Dendritic Cell Vaccine
    788. Recombinant Human Papillomavirus Nonavalent Vaccine
    789. Recombinant Modified Vaccinia Ankara-5T4 Vaccine
    790. Recombinant MUC1-DHBcAg fusion protein vaccine
    791. Recombinant MUC1-Maltose-Binding Protein (MBP) fusion protein vaccine
    792. Recombinant NY-ESO-1 ISCOMATRIX Vaccine
    793. Recombinant NY-ESO-1 Protein vaccine adjuvanted with Imiquimod
    794. Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207
    795. Recombinant Vaccinia DF3/MUC1 Vaccine
    796. Recombinant Vaccinia PSA Vaccine
    797. Recombinant Vaccinia Viral Vector RO5217790 Vaccine
    798. Recombinant Vaccinia Virus Encoding Human MUC1 and IL-2 (TG1031)
    799. Recombinant Vaccinia-CEA Vaccine
    800. Recombinant Vaccinia-CEA(6D)-TRICOM Vaccine
    801. Recombinant Vaccinia-gp100:209-217 Vaccine
    802. Recombinant Vaccinia-Mgp100 Vaccine
    803. Recombinant Vaccinia-MUC-1 Vaccine
    804. Recombinant Vaccinia-MUC1-B7 Vaccine
    805. Recombinant Vaccinia-Multiepitope Melanoma Peptides-B7.1-B7.2 Vaccine
    806. Recombinant Vaccinia-NY-ESO-1 Vaccine
    807. Recombinant Vaccinia-Prostate Specific Antigen Vaccine
    808. Recombinant Vaccinia-PSA/PSMA Vaccine
    809. Recombinant Vaccinia-TRP1 Vaccine
    810. Remestemcel-L Vaccine
    811. Renal Cell Carcinoma Peptides Vaccine IMA901
    812. Renal Cell Carcinoma/CD40L RNA-Transfected Autologous Dendritic Cell Vaccine AGS-003
    813. Renal Tumor-Reactive Autologous Peripheral Blood Lymphocyte Vaccine
    814. Retrovector Encoding Mutant Anti-Cyclin G1 Vaccine
    815. Retroviral Vector MFGS-MOv18-gamma Vaccine
    816. rF-MUC1(DF3)/TRICOM Vaccine
    817. rF-PSA/PSMA/TRICOM Vaccine
    818. Rha-Conjugated Liposomal Pam3CysSK4-DBCO-MUC1-Tn Vaccine
    819. Rha-decorated liposomal Pam3Cys-MUC1-Tn vaccine
    820. Rilimogene-galvacirepvec Vaccine
    821. RIPO(H3.3)
    822. rMCMV-TRP2
    823. rMeV- SCD
    824. rMVTT- HPV16-E6/E7
    825. Sargramostim Plasmid DNA Melanoma Vaccine Adjuvant
    826. Sargramostim Plasmid DNA Pancreatic Tumor Cell Vaccine
    827. SCIB1 DNA vaccine
    828. secPD-L1
    829. Self-Adjuvanting AuNP MUC1 Glycopeptide Vaccine with S-Glycosidic Linkage (SThr) and (4S)-4-fluoro-L-proline
    830. Self-Adjuvanting MUC1-PADRE-Pam3CysSer Tricomponent Vaccines (unglycosylated/Tn/T)
    831. Self-Adjuvanting Pam2CysSK4-MUC1(27-mer)-diTn Vaccine ± PADRE
    832. Ser17-STn-MUC1-TTox Vaccine
    833. short overlapping peptides and full-length recombinant protein
    834. Sialyl Lewis-keyhole limpet hemocyanin conjugate vaccine
    835. Sialyl Tn-KLH Vaccine
    836. Sialyl-Tn-MUC1(22)-TTox conjugate vaccine (T6-APDTRP or S17/T18-GSTA variants)
    837. Sialylated MUC1-Tn Glycopeptide-BSA Conjugate Vaccine
    838. Sipuleucel-T Vaccine
    839. Site-78 Azido-Phenylalanine-Incorporated HBc-VLP-MUC1(Tn) Conjugate Vaccine [HBc-N3(78)-MUC1 VLPs]
    840. Site-Specifically Conjugated CRM197-MUC1 APDTRP Glycopeptide Vaccine with S-Glycosidic Tn and (4S)-4-Fluoro-L-Proline
    841. smallpox vaccine
    842. sp²-Iminosugar Tn Mimic MUC1 Glycopeptide-KLH Conjugate Vaccine
    843. SRL172
    844. STn-KLH plus Detox Vaccine
    845. STn-MUC1-CRM197 Conjugate Vaccine with MPL/QS21
    846. STn-MUC1-TTox vaccine
    847. Survivin Antigen Vaccine DPX-Survivac
    848. Survivin Sur1M2 Peptide Vaccine
    849. Survivin/p53/HER2 Antigen-loaded Autologous Dendritic Cell Vaccine
    850. SVN53-67/M57-KLH Peptide Vaccine
    851. Synchotrope TA2M Vaccine
    852. Synchrotope TA2M Plasmid DNA Vaccine
    853. Synchrovax SEM Plasmid DNA Vaccine
    854. Synthetic Breast Cancer Peptides-Tetanus Toxoid-Montanide ISA-51 Vaccine
    855. Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine Therapy APVAC2
    856. Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1
    857. Synthetic hTERT DNA Vaccine INO-1400
    858. Synthetic Long E6/E7 Peptides Vaccine HPV-01
    859. Synthetic Melanoma-Associated Antigens Vaccine
    860. Synthetic Peptides E-PRA And E-PSM Vaccine
    861. SZU251 + MUC1 + Al vaccine
    862. T-glycosylated MUC1–YSYFPSV–Pam₃CysSer Tricomponent Vaccine
    863. TARP 27-35 Peptide Vaccine
    864. TARP 29-37-9V Peptide Vaccine
    865. TBC-CEA-Contaminated W/ BVDV Vaccine
    866. Telomerase Peptide Vaccine GV1001
    867. Telomerase-specific Type 5 Adenovirus OBP-301 Vaccine
    868. Telomerase: 540-548 Peptide Vaccine
    869. Tergenpumatucel-L Vaccine
    870. Tetanus peptide melanoma vaccine
    871. Tetraphenylethylene (TPE)-(alpha-S-GalNAc)3-P30-Tn-MUC1 Tripartite Vaccine
    872. Tetravalent MUC1-STn Glycopeptide-Pam3CSK4 Vaccine
    873. Tetravalent RNA-lipoplex Cancer Vaccine
    874. TGFβ2 Antisense-GMCSF Gene Modified Autologous Tumor Cell Vaccine
    875. Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
    876. Thioether-Conjugated MUC1-diTn-P2-Pam3CSK4 Vaccine
    877. TICE BCG
    878. TLR-9/GM Vaccine
    879. TLR7 Agonist (SZU101)-Conjugated MUC1 Peptide Vaccine
    880. TLR7a-BSA-MUC1 Self-Adjuvanting Conjugate Vaccine
    881. Tn(c)-KLH Conjugate Vaccine
    882. Total Tumor RNA-loaded Dendritic Cell Vaccine
    883. TRAF6-Overexpressing Bone Marrow-Derived DC Vaccine Loaded with MUC1 Peptide
    884. Transgenic Lymphocyte Immunization Vaccine
    885. Tri-Tn MUC1 Glycopeptide-P30 Vaccine
    886. TriAd Cancer Vaccine
    887. TriMixDC-MEL Vaccine
    888. Tripartite Branched Penetratin-Multiple Antigen Peptide (MAP)-MUC1 VNTR-Tetanus Toxoid Vaccine [AntpMAPMUC1tet]
    889. TRP-2: 180-188 Peptide Vaccine
    890. TRP1(0RF3):1-9 Peptide Vaccine
    891. Tumor antigen-sensitized DC vaccine
    892. Tumor Cell Derivative Vaccine
    893. Tumor Lysate-pulsed Dendritic Cell Vaccine
    894. Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine
    895. TVI-Brain-1
    896. Tyrosinase-KLH Vaccine
    897. tyrosinase240–251S, 368-376D Vaccine
    898. Unconjugated Lymphoma Ig Id Vaccine
    899. Unconjugated Myeloma Ig Id Vaccine
    900. URLC10 Peptide Vaccine
    901. URLC10-CDCA1-KOC1 Multipeptide Vaccine
    902. URLC10-TTK-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine
    903. UV1 Telomerase Peptide Vaccine
    904. vaccinia melanoma cell lysates (VMCL) Vaccine
    905. Vaccinia Melanoma Oncolysates (VMO) Vaccine
    906. Vaccinia Virus DD-CDSR Vaccine
    907. Vaccinia-GM-CSF Vaccine
    908. Vaccinia-Tyrosinase Vaccine
    909. VCL-CB01 Vaccine
    910. VEGFR-2 DNA Vaccine VXM01
    911. VEGFR1-1084 Peptide Vaccine
    912. VEGFR2-169 Peptide Vaccine
    913. Verpasep Caltespen Vaccine
    914. VHL-42: 65-76(V74G) Peptide Vaccine
    915. VHL-59: 116-128 Peptide Vaccine
    916. VHL14 Peptide Vaccine
    917. VHL16 Peptide Vaccine
    918. VHL2 (Y12M) Peptide Vaccine
    919. Vi Capsular Polysaccharide Typhoid Vaccine
    920. Viagenpumatucel-L Vaccine
    921. VMCL
    922. Von Hippel-Lindau Peptide Vaccine
    923. Whole tumor cell-based leukemia vaccine
    924. WT1 124-138 Peptide Vaccine
    925. WT1 126-134 Peptide Vaccine
    926. WT1 235-243 Peptide Vaccine
    927. WT1 247-261 Peptide Vaccine
    928. WT1 Analog Peptide Vaccine
    929. WT1 Peptide Vaccine OCV-501
    930. WT1 Peptide Vaccine WT2725
    931. WT1 Trio Peptide Vaccine
    932. WT1-A10/AS01B Immunotherapeutic GSK2130579A Vaccine
    933. XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410
    934. Xenogeneic Tyrosinase DNA Vaccine
    935. β-(1,3)-Glucan–MUC1 Conjugate Vaccine
  4. References
I. General Information
1. Disease:
Cancer
2. Introduction
Cancer is a class of diseases in which a group of cells display uncontrolled growth (division beyond the normal limits), invasion (intrusion on and destruction of adjacent tissues), and sometimes metastasis (spread to other locations in the body via lymph or blood). These three malignant properties of cancers differentiate them from benign tumors, which are self-limited, and do not invade or metastasize. Most cancers form a tumor but some, like leukemia, do not. The branch of medicine concerned with the study, diagnosis, treatment, and prevention of cancer is oncology.

Cancer affects people at all ages with the risk for most types increasing with age. Cancer caused about 13% of all human deaths in 2007 (7.6 million). Cancers are caused by abnormalities in the genetic material of the transformed cells. These abnormalities may be due to the effects of carcinogens, such as tobacco smoke, radiation, chemicals, or infectious agents. Other cancer-promoting genetic abnormalities may randomly occur through errors in DNA replication, or are inherited, and thus present in all cells from birth. The heritability of cancers is usually affected by complex interactions between carcinogens and the host's genome.

Genetic abnormalities found in cancer typically affect two general classes of genes. Cancer-promoting oncogenes are typically activated in cancer cells, giving those cells new properties, such as hyperactive growth and division, protection against programmed cell death, loss of respect for normal tissue boundaries, and the ability to become established in diverse tissue environments. Tumor suppressor genes are then inactivated in cancer cells, resulting in the loss of normal functions in those cells, such as accurate DNA replication, control over the cell cycle, orientation and adhesion within tissues, and interaction with protective cells of the immune system.

Definitive diagnosis requires the histologic examination of a biopsy specimen, although the initial indication of malignancy can be symptomatic or radiographic imaging abnormalities. Most cancers can be treated and some forced into remission, depending on the specific type, location, and stage. Once diagnosed, cancer is usually treated with a combination of surgery, chemotherapy and radiotherapy. As research develops, treatments are becoming more specific for different varieties of cancer. There has been significant progress in the development of targeted therapy drugs that act specifically on detectable molecular abnormalities in certain tumors, and which minimize damage to normal cells. The prognosis of cancer patients is most influenced by the type of cancer, as well as the stage, or extent of the disease. In addition, histologic grading and the presence of specific molecular markers can also be useful in establishing prognosis, as well as in determining individual treatments (Wiki: Cancer).
Loading...
Loading Pathogen Genes...
Loading...
Loading Host Genes...
Loading...
Loading Vaccines...
Loading References...